Astrocytic P2X7 receptor regulates depressive-like behavioral reactions of mice in response to acute stressful stimulation

share:

Brief intro:

Products/Services used in the paper

Quotation shows PackGene:The following viruses were purchased from Guangzhou PackGene Biotechnology Co., Ltd. (Guangzhou, China): neuron-specific (driven by human synapsin promoter): AAV9_hSyn-EGFP-miR30shRNA(mP2X7)-WPRE-SV40pA and AAV9_hSyn-EGFP-miR30shRNA(NC)-WPRE-SV40pA; astrocyte-specific (driven by 681 bp GFAP promoter): AAV8_GFAP(681 bp)-EGFP-miR30shRNA(mP2X7)-WPRE-SV40pA and AAV8_GFAP(681 bp)-EGFP-miR30shRNA(NC)-WPRE-SV40pA; and microglia-specific (driven by Iba1 promoter): AAV9_Iba1-EGFP-miR30shRNA(mP2X7)-WPRE-SV40pA and AAV9_Iba1-EGFP-miR30shRNA(NC)-WPRE-SV40pA.

Research Field:depressive-like behavioral reactions

AAV Serotype:AAV9

Targeted organ:hippocampal tissue

Animal or cell line strain:mice

Request Quote

Abstract

Acute stress causes depressive-like reactions in the tail suspension (TST) and forced swim tests (FST) of mice. Similarly, inescapable foot shock is able to promote the development of anhedonia as indicated by decreased sucrose consumption of treated mice in the sucrose preference test (SPT). The astrocyte-specific deletion of the P2X7R by a conditional knockout strategy or its knockdown by the intracerebroventricular (i.c.v.) delivery of an adeno-associated virus (AAV) expressing P2X7R-specific shRNA in astrocytes significantly prolonged the immobility time in TST and FST. In contrast, the shRNA-induced downregulation of the P2X7R in neurons, oligodendrocytes, or microglia had no detectable effect on the behavior of treated mice in these tests. Moreover, sucrose consumption in the SPT was not altered following inescapable foot shock treatment in any of these cell type-specific approaches. Immunohistochemistry indicated that the administered astrocyte-specific AAV efficiently conveyed expression of shRNA by hippocampal CA1 astrocytes, but not by neurons. In conclusion, P2X7R in astrocytes of this area of the brain appears to be involved in depressive-like reactions to acute stressors.

About PackGene

PackGene Biotech is a world-leading CRO and CDMO, excelling in AAV vectors, mRNA, plasmid DNA, and lentiviral vector solutions. Our comprehensive offerings span from vector design and construction to AAV, lentivirus, and mRNA services. With a sharp focus on early-stage drug discovery, preclinical development, and cell and gene therapy trials, we deliver cost-effective, dependable, and scalable production solutions. Leveraging our groundbreaking π-alpha 293 AAV high-yield platform, we amplify AAV production by up to 10-fold, yielding up to 1e+17vg per batch to meet diverse commercial and clinical project needs. Moreover, our tailored mRNA and LNP products and services cater to every stage of drug and vaccine development, from research to GMP production, providing a seamless, end-to-end solution.

Download